 Building upon demonstrated clinical success, the pivotal study will evaluate the Selective Cytopheretic Device in adults with AKI requiring CKRT DENVER, Jan. 09, 2023 GLOBE NEWSWIRE SeaStar Medical Nasdaq: ICU, a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, has submitted an investigational device exemption IDE application ... The post SeaStar Medical Submits Investigational Device Exemption IDE Application... 